April 2024

BioHarvest

BioHarvest Sciences Reports Fourth Quarter and Full Year 2023 Financial Results

2024, Uncategorized /

Vancouver, British Columbia and Rehovot, Israel – April 30, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today reported its financial and operational results for the fourth quarter and full year ended December 31, 2023. The Company is also announcing an […]

BioHarvest Sciences Reports Fourth Quarter and Full Year 2023 Financial Results Read More »

BioHarvest Sciences Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity

2024 /

Vancouver, British Columbia and Rehovot, Israel – April 16, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a biotechnology company pioneering its patented Botanical Synthesis technology process, today announced the signing of two agreements: a long term lease agreement  for a new 80,000 square ft. facility  in Yavne, Israel, and an

BioHarvest Sciences Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity Read More »

BioHarvest Sciences Announces Conversion of Debt Notes

2024 /

Vancouver, British Columbia and Rehovot, Israel – April 3, 2024 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF), a biotechnology company pioneering its patented Botanical Synthesis technology platform, today announced an early conversion of convertible debt notes, associated with the convertible debt financing rounds completed on October 2022, November 2022, July

BioHarvest Sciences Announces Conversion of Debt Notes Read More »